It has been shownthat PRMT5 inhibition by small molecules canselectively kill cancer cells with homozygous deletion of the MTAP gene if the inhibitors can leverage the consequenceof MTAP deletion, namely, accumulation of the MTAPsubstrate MTA. The gene discussed is MTAP; the disease is cancer.